ARCHIVES

CTEP Drafts FDA Approval Guidelines

This article is from The Cancer Letter archive.

Vol. 14 No. 10 | March 4, 1988

Download PDF Visit The Full Archive

Related Articles

MSKCC hopes to raise $1 billion in five-year campaign.

November 7, 2003

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Research vs. Delivery? Advisors Debate NCI Role In Review of Community Program.

November 21, 2008

Clinical Trials Approved By NCI Last Month Are Listed

April 25, 2003

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005